Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 1998
Business Overview: The Company manufactures and distributes natural health and nutritional products through a direct sales network of independent Managers and Distributors. Operations are split between Domestic and International segments.
Key Financial Metrics (Six Months Ended June 30, 1998)
| Metric | 1998 (in thousands) | 1997 (in thousands) |
|---|---|---|
| Sales Revenue | $152,484 | $139,236 |
| Net Income | $10,972 | $9,256 |
| Operating Income | $17,081 | $14,377 |
| Net Cash from Operating Activities | $19,218 | $17,144 |
| Cash and Cash Equivalents (End of Period) | $34,970 | $28,861 |
| Short-Term Debt | $1,828 | $2,665 |
| Basic EPS | $0.59 | $0.49 |
| Diluted EPS | $0.58 | $0.48 |
Margins (Six Months 1998):
- Gross Margin (Sales less COGS): 82.2%
- Operating Margin: 11.2%
- Net Profit Margin: 7.2%
Material Changes vs. Prior Period
- Revenue Growth: Sales revenue increased 9.5% year-over-year to $152.5 million, driven by a 10% increase in domestic sales and an 8% increase in international sales.
- Profitability: Net income rose 18.5% to $11.0 million. Operating income increased 18.8% to $17.1 million.
- Expense Trends:
- Cost of Goods Sold (COGS): Decreased as a percentage of sales (17.8% vs 18.3% prior year) due to a 2% domestic price increase in April 1998.
- Volume Incentives: Increased 9.2% in absolute terms but remained relatively constant as a percentage of sales (46.4%).
- SG&A Expenses: Increased 8.3% year-over-year, primarily due to costs associated with sales conventions and travel programs.
- Balance Sheet: Cash and cash equivalents increased by $7.2 million. Accounts receivable increased by $1.6 million due to international growth. Accrued liabilities increased by $4.4 million, largely due to convention accruals.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects COGS and volume incentives to remain relatively constant as a percentage of sales for the remainder of 1998. SG&A is expected to decrease as a percentage of sales.
- International Strategy: International sales growth was dampened by the strong U.S. dollar. Price increases are planned in markets such as Brazil, Colombia, Venezuela, Mexico, and Japan to offset currency devaluation.
- Unusual Items: Operating income was impacted by losses from the South Korea subsidiary, which began operations in late 1997. The Asia Pacific segment reported an operating loss of $1.2 million for the six-month period.
- Capital Allocation: The Company is executing a 500,000 share buyback program. 236,000 shares were purchased in the first six months of 1998. A quarterly dividend of 3 1/3 cents per share was declared.
- Risks:
- Liquidity: While current cash flow is strong, a prolonged economic downturn or decrease in product demand could adversely affect long-term liquidity. The Company currently has no external credit facility.
- Year 2000 Issue: The Company is monitoring internal systems and third-party providers for Y2K compliance but notes no assurance that operational difficulties will not occur.
- Legal: The Company is a defendant in various incidental lawsuits, which management believes will not have a material effect.
Investor Verification Checklist
- International Currency Impact: Verify the effectiveness of planned price increases in key international markets (Brazil, Colombia, Venezuela, Mexico, Japan) to counteract the strong U.S. dollar.
- South Korea Operations: Monitor the performance of the South Korea subsidiary, which contributed to operating losses in the Asia Pacific segment.
- SG&A Control: Confirm that SG&A expenses decrease as a percentage of sales in the second half of 1998 as management projects, following the convention-related spike in Q2.
- Distributor Trends: Note the decrease in total Distributors (from 660,000 to 619,000) despite an increase in Managers; verify if this shift in the sales force structure impacts long-term revenue stability.
- Capital Expenditures: Confirm the completion and utilization of the new domestic manufacturing and warehouse facility, which cost approximately $6.2 million.